Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Ammonia Solution, Strong. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL918668 | 0.87 | — | — | |
| Ammonia Solution, Strong SCHEMBL1702257 | 0.87 | — | — | |
| Water SCHEMBL19065032 | 0.87 | — | — | |
| Ammonia Solution, Strong SCHEMBL59674 | 0.87 | — | — | |
| Water SCHEMBL10835633 | 0.87 | — | — | |
| Water SCHEMBL5595448 | 0.87 | — | — | |
| Ammonia Solution, Strong SCHEMBL715518 | 0.87 | — | — | |
| Ammonia Solution, Strong SCHEMBL11027260 | 0.87 | — | — | |
| Water SCHEMBL15845181 | 0.87 | — | — | |
| Ammonia Solution, Strong SCHEMBL9180593 | 0.87 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6183711-B1 | ADMINISTERING A PARTIALLY ALKYLATED XANTHINE FOR TREATING BONE DISORDER BY FORMING APATITE WITH INCREASED THE CRYSTALLITE SIZE | Nakamoto, Tetsuo | 2001-02-06 | — | — | US | disclosed |
| EP-0610333-B1 | TREATED APATITE PARTICLES FOR MEDICAL DIAGNOSTIC IMAGING | MALLINCKRODT INC (US) | 2001-01-03 | — | — | EP | disclosed |
| EP-0693904-A4 | TREATED CALCIUM/OXYANION-CONTAINING PARTICLES FOR MEDICAL DIAGNOSTIC IMAGING | MALLINCKRODT MEDICAL INC (US) | 1998-05-06 | — | — | EP | disclosed |
| US-5609850-A | Treated apatite particles for ultrasound imaging | MALLINCKRODT MEDICAL, INC. (US) | 1997-03-11 | — | — | US | disclosed |
| US-5595724-A | Treated calcium/oxyanion-containing particles for medical diagnostic imaging | DEUTSCH EDWARD A (US) | 1997-01-21 | — | — | US | disclosed |
| EP-0693904-A1 | TREATED CALCIUM/OXYANION-CONTAINING PARTICLES FOR MEDICAL DIAGNOSTIC IMAGING | MALLINCKRODT MEDICAL, INC. (US) | 1996-01-31 | — | — | EP | disclosed |
| US-5468465-A | ENHANCING X-RAY IMAGES OF BODY ORGANS AND TISSUES | MALLINCKRODT MEDICAL, INC. (US) | 1995-11-21 | — | — | US | disclosed |
| WO-1994023649-A1 | TREATED CALCIUM/OXYANION-CONTAINING PARTICLES FOR MEDICAL DIAGNOSTIC IMAGING | MALLINCKRODT MEDICAL, INC. (US) | 1994-10-27 | — | — | WO | disclosed |
| EP-0610333-A1 | TREATED APATITE PARTICLES FOR MEDICAL DIAGNOSTIC IMAGING | MALLINCKRODT MEDICAL, INC. (US) | 1994-08-17 | — | — | EP | disclosed |
| US-5218757-A | TAPERED CARBON MICROELECTRODE AND PROCESS FOR PRODUCTION THEREOF | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1993-06-15 | — | — | US | disclosed |
| WO-1993007905-A2 | TREATED APATITE PARTICLES FOR MEDICAL DIAGNOSTIC IMAGING | MALLINCKRODT MEDICAL, INC. (US) | 1993-04-29 | — | — | WO | disclosed |
| US-4861913-A | Bicyclic sulfonamide derivatives | SHIONOGI & CO., LTD. (JP) | 1989-08-29 | — | — | US | disclosed |
| EP-0081341-A1 | Record material | The Wiggins Teape Group Limited (GB) | 1983-06-15 | — | — | EP | disclosed |